Navigation Links
Angiotech to participate in RBC 2007 Healthcare Conference
Date:12/6/2007

VANCOUVER, Dec. 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the RBC 2007 Healthcare Conference, which is being held December 12-13 in New York, NY.

Tom Bailey, Angiotech's Chief Financial Officer, is scheduled to participate in a panel discussion on Thursday, December 13, at the Westin New York Times Square, beginning at approximately 9:00am ET.

A live audio-only webcast will be available to all interested parties on the company's website, http://www.angiotech.com under the Investors section.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.

CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
11. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ...harmaceutical company focused on endocrine therapy...and Drug Administration (FDA) has granted Fast Tra...inhibitor compound, perifosine (KRX-0401), for the.... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX)...
(Date:12/2/2009)...PRNewswire/ -- According to the National Institute...diagnosed with diabetes already have some stage of...ge to the retina caused by leaky blood vessels, is...s and is one of the most feared diabetic complicat...ho,ve had diabetes for 10 years or more will exper...
(Date:12/1/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Chromium - Global Market Trends ,...m---Global-Market-Trends.html ,, Worldwide dem...ess steel, while growth in aerospace and industria... of chromium metal. Environmental constraints and ...
(Date:12/1/2009)... Harvest Technologies Corp. ( www.h...company sponsored 60-patient clinical trial conduc...India using the company,s BMAC System to treat pat...mia (CLI). Sri Ramachandra Medical Center is a Har...based in Chennai, India and one of the largest pri...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...ILL OFFER DNA TESTING FOR $59.95, THE MOST AFFORDA... ANYWHERE -, SAN DIEGO, Sept. 8 Familybuilder t...e in San Diego, the launch of the,Familybuilder Gl...ilybuilder.com ) and the introduction of $59.95 D... anywhere., At Familybuilder.com, people can now ...
... A free paper helps visitor...such as finding multilingual help, electronica inf... of pre-show information useful in planning a trip... areas, conferences and events. It includes an ext...d show resources. , Munic...
...You should have so much patience to solder nanowir...ometer is a billionth of a meter.) , That,s why a...ins many silicon nanowires to many prepatterned el...Nanotech Briefs. , The process removes many diffi...parallel," says Sean Hearne, a Sandia National Lab...
Other Biology Technology:Familybuilder Launches the Familybuilder Global Network at DEMOfall 08 2Familybuilder Launches the Familybuilder Global Network at DEMOfall 08 3Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 3Parallel 'nano-soldering' technique chosen for year's top-50 by Nanotech Briefs 2
(Date:12/2/2009)...ore the thought telling it to flex can race down y...channelmust open in the surface of each cell in th...r the cell to action. New research* at the Nationa... allowed scientists to observe ion channels within...lly offering insights for future drug development....
(Date:12/2/2009)...y of Southampton,s School of Ocean and Earth Scien...thampton (NOCS) has formally described four new sp...l discovered the new species in the Smithsonian Co...y in Washington. Explaining the significance of th...largest crustaceans currently inhabiting Earth and...
(Date:12/1/2009)...ounce the publication of results from its Phase II...erability of its novel, intranasal drug/device pro...usitis with nasal polyps in Rhinology , the offic...ologic Societies. , Chronic rhinosinusitis with...icantly reduce a patient,s quality of life, causin...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2King crab family bigger than ever 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting 5506 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 4Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 1Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 2
...titis C Virus (HCV) infects up to 500,000 people i...gnosed. It is the single biggest cause of people r...collaborative effort with groups across Europe and...gham have found monoclonal antibodies which may be...s C treatment is expensive and not successful in a...
...nheim, September 04, 2007 - The term "biotechnolog...e to fear and hostility. Alan McHughen from the Un...reviews at large the current state public knowledg...lliteracy and the role of the media. How is coexis...s from agricultural biotech only big companies or...
...MBUS, Ohio More than a third of college athletes ...uggesting exercise-induced asthma, even in those a...ew study shows. , The findings, published in the... in Sports & Exercise, paralleled earlier findings...mong Olympic athletes. The work also underscores t...
Other Biology News:Possible hepatitis C vaccine 2How the public perceives biotech 2Study finds a high rate of asthma in college athletes 2
Affi-Prep Protein A Support, 25 ml from Bio-Rad
...of Protein Standards, a growing family of lyophili..., molecular biology, and life science laboratories...fied proteins for use in the calibration of protei...metry (ESI-MS). For quality control and standardi...
Big CHAP, Deoxy from Calbiochem
PIP Array from Echelon Biosciences Inc.
Biology Products: